Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313231500> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4313231500 endingPage "48" @default.
- W4313231500 startingPage "42" @default.
- W4313231500 abstract "Interferon inducers are of interest as the first line of defense against viral infections, including influenza. Double-stranded ribonucleic acid (dsRNA) for intranasal administration has been developed, the excipients and drug components were selected at the Institute of Medical Biotechnology, a branch of the State Research Center of Virology and Biotechnology «Vector». This work presents the results of the study on antiviral activity and pharmacological safety of a new form of dsRNA. The antiviral activity of the preparation was studied in BALB/c mice infected with influenza A/Aichi/2/68 (H3N2) or Bishkek/01/2009 (H1N1pdm09) viruses. A safety study was performed with a single administration of intranasal dsRNA into white outbred ICR mice. The study showed that the administration of therapeutic and prophylactic regimen of intranasal dsRNA at a dose of 2.5 mg/kg increases the survival and average life expectancy of mice infected with the mentioned strains of influenza virus. The protective effect of the preparation in mice infected with a lethal dose of Bishkek/01/2009 virus was comparable to the effect of Tamiflu. The absence of toxic effects of intranasal dsRNA at a pharmacological dose in laboratory mice, the functional state of their physiological systems, as well as main types of metabolism, established in the experiments, lead to a conclusion concerning pharmacological safety of the preparation and the prospects for further work to complete pharmaceutical development of a new antiviral drug." @default.
- W4313231500 created "2023-01-06" @default.
- W4313231500 creator A5001935147 @default.
- W4313231500 creator A5006498694 @default.
- W4313231500 creator A5009718766 @default.
- W4313231500 creator A5025166855 @default.
- W4313231500 creator A5037145612 @default.
- W4313231500 creator A5041321136 @default.
- W4313231500 creator A5053481284 @default.
- W4313231500 creator A5056291541 @default.
- W4313231500 creator A5069307470 @default.
- W4313231500 creator A5071189969 @default.
- W4313231500 creator A5084820158 @default.
- W4313231500 date "2022-12-28" @default.
- W4313231500 modified "2023-09-30" @default.
- W4313231500 title "Study on Antiviral Activity and Pharmacological Safety of Double-Stranded Ribonucleic Acid for Intranasal Administration" @default.
- W4313231500 cites W2968244059 @default.
- W4313231500 doi "https://doi.org/10.37489/0235-2990-2022-67-9-10-42-48" @default.
- W4313231500 hasPublicationYear "2022" @default.
- W4313231500 type Work @default.
- W4313231500 citedByCount "0" @default.
- W4313231500 crossrefType "journal-article" @default.
- W4313231500 hasAuthorship W4313231500A5001935147 @default.
- W4313231500 hasAuthorship W4313231500A5006498694 @default.
- W4313231500 hasAuthorship W4313231500A5009718766 @default.
- W4313231500 hasAuthorship W4313231500A5025166855 @default.
- W4313231500 hasAuthorship W4313231500A5037145612 @default.
- W4313231500 hasAuthorship W4313231500A5041321136 @default.
- W4313231500 hasAuthorship W4313231500A5053481284 @default.
- W4313231500 hasAuthorship W4313231500A5056291541 @default.
- W4313231500 hasAuthorship W4313231500A5069307470 @default.
- W4313231500 hasAuthorship W4313231500A5071189969 @default.
- W4313231500 hasAuthorship W4313231500A5084820158 @default.
- W4313231500 hasBestOaLocation W43132315001 @default.
- W4313231500 hasConcept C159047783 @default.
- W4313231500 hasConcept C2522874641 @default.
- W4313231500 hasConcept C2780035454 @default.
- W4313231500 hasConcept C71924100 @default.
- W4313231500 hasConcept C85663871 @default.
- W4313231500 hasConcept C86803240 @default.
- W4313231500 hasConcept C98274493 @default.
- W4313231500 hasConceptScore W4313231500C159047783 @default.
- W4313231500 hasConceptScore W4313231500C2522874641 @default.
- W4313231500 hasConceptScore W4313231500C2780035454 @default.
- W4313231500 hasConceptScore W4313231500C71924100 @default.
- W4313231500 hasConceptScore W4313231500C85663871 @default.
- W4313231500 hasConceptScore W4313231500C86803240 @default.
- W4313231500 hasConceptScore W4313231500C98274493 @default.
- W4313231500 hasIssue "9-10" @default.
- W4313231500 hasLocation W43132315001 @default.
- W4313231500 hasOpenAccess W4313231500 @default.
- W4313231500 hasPrimaryLocation W43132315001 @default.
- W4313231500 hasRelatedWork W1535571949 @default.
- W4313231500 hasRelatedWork W2016551366 @default.
- W4313231500 hasRelatedWork W2032802917 @default.
- W4313231500 hasRelatedWork W2056772893 @default.
- W4313231500 hasRelatedWork W2064284877 @default.
- W4313231500 hasRelatedWork W2123163123 @default.
- W4313231500 hasRelatedWork W2138564085 @default.
- W4313231500 hasRelatedWork W2142062823 @default.
- W4313231500 hasRelatedWork W2188759708 @default.
- W4313231500 hasRelatedWork W2400613564 @default.
- W4313231500 hasVolume "67" @default.
- W4313231500 isParatext "false" @default.
- W4313231500 isRetracted "false" @default.
- W4313231500 workType "article" @default.